Avecia clears regulatory hurdles for biotech manufacturing
This article was originally published in Scrip
Executive Summary
The privately owned UK contract manufacturer Avecia Biologics has received a manufacturer's licence from the UK regulatory authority, the MHRA, adding to its first successful US FDA pre-approval inspection, which it underwent earlier this year.